The stock is in a sustained uptrend, having gained 22.33% over the past six months and 15.58% year-to-date, significantly outperforming the S&P 500's 8.7% YTD gain. Currently trading at $40.05, the price sits at approximately 32% of its 52-week range ($31.63 to $44.14), indicating it is positioned closer to the lower bound of its recent high range, which may suggest a consolidation phase after a strong run rather than immediate overextension. Recent momentum shows acceleration, with a 1-month gain of 8.39% and a 3-month gain of 6.74%, both outpacing the broader market's 4.59% and 8.29% gains over the same periods, respectively, signaling strong near-term buying pressure. However, the 1-year price change of 3.14% lags the S&P 500's 25.03% surge, highlighting a period of underperformance that the recent rally is attempting to reverse, suggesting a potential catch-up trade is underway. Key technical support is firmly established at the 52-week low of $31.63, while immediate overhead resistance lies near the recent highs around $44.14. A decisive breakout above the $44.14 resistance would signal a resumption of the primary uptrend and could target new highs, whereas a breakdown below the $31.63 support would indicate a failure of the recent recovery and potentially lead to a test of lower levels. The stock exhibits a beta of 0.522, meaning it is approximately 48% less volatile than the broader market, which is characteristic of a defensive, income-oriented midstream entity and implies lower systematic risk for portfolio positioning. The stock's relative strength metrics are mixed, showing a 1-month relative strength of +3.80% versus the S&P 500 but a 1-year relative weakness of -21.89%, confirming the divergence between its recent outperformance and longer-term lag. Volume data shows an average of approximately 2.57 million shares traded, and the short ratio of 4.2 indicates a moderate level of short interest, which could contribute to volatility on positive news. The maximum drawdown of -27.08% provides context for the stock's risk profile during adverse periods, which is relevant for risk-averse income investors.

Revenue growth is stable but modest, with Q4 2025 revenue of $404.2 million representing a 2.33% year-over-year increase. Sequentially, revenue declined from $420.9 million in Q3 2025, indicating some quarterly volatility, though the full-year trend remains positive, driven by its fee-based model. Segment data reveals that Affiliate Services, contributing $388.4 million, is the dominant revenue driver, while Third-Party Services at $14.7 million represents a small but potentially growth-oriented segment, underscoring the company's reliance on its sponsor relationships for predictable cash flows. The company is solidly profitable, reporting Q4 2025 net income of $93.3 million and a trailing net margin of 21.77%. Gross margin for the quarter was a healthy 63.64%, and the operating margin was 62.25%, reflecting the highly efficient, low-cost operating structure typical of midstream assets. Profitability has been consistent, with net income growing from $70.4 million in Q4 2024 to $93.3 million in Q4 2025, demonstrating an improving bottom-line trajectory supported by operational leverage. Balance sheet health is a point of consideration, with a debt-to-equity ratio of 6.64, indicating a highly leveraged capital structure common for MLPs focused on distribution growth and asset expansion. However, the company generates robust cash flow, with trailing twelve-month free cash flow of $584.8 million and an operating cash flow of $245.6 million for Q4 2025, providing coverage for its obligations. The current ratio of 0.85 suggests adequate but not excessive liquidity, and the return on equity of 62.10% is exceptionally high, largely amplified by the significant financial leverage.